Announcements
View latest announcements here.
2112 items
16 November 2026
Recall of Farganesse Injection 50mg/2ml (promethazine)
Audiences
Healthcare professional
Product-type
Therapeutic Products
Retail-level recall of one batch of Farganesse Injection 50mg/2ml, containing promethazine due to presence of particles in the ampoules.
16 November 2026
Regulatory Updates (16 Nov 2026)
Audiences
Industry member
As part of HSA’s ongoing efforts to enhance regulatory clarity and improve regulatory processes, the Medicinal Products Cluster is pleased to share the following updates with industry stakeholders:
6 November 2026
Recall of Meravo Film-coated Tablet 100mg
Audiences
Healthcare professional
Product-type
Therapeutic Products
Retail-level recall of one batch of Meravo Film-coated Tablet 100mg (SIN16873P), due to out-of-specification results in stability study
5 November 2026
Malaysian Vape Pod Importer Jailed for 18 Months
5 November 2026
Recall of AGELMIN TABLET 10 mg
Audiences
Healthcare professional
Product-type
Therapeutic Products
Retail-level recall of one batch of AGELMIN TABLET 10 mg due to failed dissolution test results.
4 November 2026
Safeguarding patients from adulterated complementary health products: Responsibilities of TCM practitioners
Audiences
Healthcare professional
Product-type
Chinese Proprietary Medicines
Others
Traditional medicines
2 November 2026
Report suspected side effects from medicines to your healthcare professional
Audiences
Consumer
Healthcare professional
Product-type
Therapeutic Products
1 November 2026
Recall of Tetrabenazine 25mg 112’s Sun-Italy
Audiences
Healthcare professional
Product-type
Therapeutic Products
Retail-level recall of one batch of Tetrabenazine 25mg 112’s Sun-Italy, containing tetrabenazine, due to presence of black spots on the tablets.
29 October 2026
HSA Charges 38-Year-Old Male for Alleged Trafficking of Etomidate Vaporiser Pods
Audiences
Consumer
Healthcare professional
Industry member
Product-type
Tobacco control
26 October 2026
Mean applicant screening response time
Audiences
Industry member
HSA’s target screening turn-around-time from the date of receipt of the application dossier to the date of acceptance or non-acceptance/withdrawal of the application (excluding applicant’s response time) is 50 working days (WD).
